BioWorld - Friday, February 13, 2026

BioWorld Science

Nov. 26, 2021

View Archived Issues

CT-859 improves survival in a murine NASH model

Read More

New animal model reveals effects of TM6SF2 gene variant on VLDL lipidation

Read More

Preclinical data presented for recombinant myxoma virus MC509-N1 in cancer

Read More

Adenosine A2A receptor antagonists identified at Adorx Therapeutics

Read More

New MAP4K1 inhibitors synthesized at Pfizer

Read More

Takeda Pharmaceutical presents new ABCC2 inhibitors

Read More

Merck, Cancer Research Technology divulge YAP1/TEAD interaction inhibitors

Read More

Sinocelltech patents Fc fragment fusion protein glycoconjugates

Read More

Study reports tumors change as patients age

Read More

Glycotope's tumor-targeting IL-15-based immunocytokine shows efficacy in preclinical models

Read More

Repurposing of riluzole for the treatment of Niemann-Pick disease, type C1

Read More

Attenuated measles vaccine expressing the S antigen protects mice and hamsters from SARS-CoV-2

Read More

SHP-1 abundance determines the responsiveness of an individual NK cell

Read More

Compounds targeting NPC1 protein show promising antiviral activity against SARS-CoV-2

Read More

Osteoclasts modified with tetracycline show efficacy in models of heterotopic ossification

Read More

ALD-2510 selectively depletes tumor-infiltrating Tregs for activity in vivo

Read More

Polycystic ovary syndrome murine model reveals CYP17 involvement

Read More